SCHEMBL1244002

SCHEMBL1244002

CNC(C)C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606457 1.00
SCHEMBL2606459 1.00
Hydrochloric Acid SCHEMBL19086802 0.96
SCHEMBL276661 0.72 TDP1 (0.33)
SCHEMBL25091473 0.72
SCHEMBL10273869 0.72
SCHEMBL12201850 0.72
SCHEMBL22216770 0.72
SCHEMBL21916823 0.72
SCHEMBL24235529 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112533902-B Composition comprising a nitroxide inhibitor, a quinone methide blocker and an amine stabilizer to inhibit polymerization of monomers 埃科莱布美国股份有限公司 2025-03-14 CN disclosed
US-12018267-B2 Plants having increased tolerance to herbicides BASF SE (DE) 2024-06-25 US disclosed
US-11992012-B2 Diaminotriazine compounds BASF SE (DE) 2024-05-28 US disclosed
EP-4370505-A1 HERBICIDAL PHENYLURACILS BASF SE (DE) 2024-05-22 EP disclosed
US-11965171-B2 Plants having increased tolerance to herbicides BASF SE (DE) 2024-04-23 US disclosed
US-11939587-B2 Plants having increased tolerance to herbicides BASF SE (DE) 2024-03-26 US disclosed
WO-2023220425-A1 BCL-XL/BCL-2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
US-20230345941-A1 HERBICIDAL PHENYLETHERS BASF SE (DE) 2023-11-02 US disclosed
US-11766044-B2 Method for controlling PPO resistant weeds BASF SE (DE) 2023-09-26 US disclosed
US-20230278977-A1 STABLE POLYMORPH OF R-MDMA HCL EMPATHBIO, INC. 2023-09-07 US disclosed
EP-1139744-A1 EXO-R-MECAMYLAMINE FORMULATION AND USE IN TREATMENT UNIVERSITY OF SOUTH FLORIDA (US) 2001-10-10 EP disclosed
EP-1127053-A1 NOVEL 1-ARYL-4-THIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2001025216-A1 1-ARYL-1,3-DIHYDRO-IMIDAZOL-2-(THI)ONE DERIVATIVES, PRODUCTION OF SAID COMPOUND AND USE AS A DESSICATING/DEFOLIATING AGENT FOR PLANTS BASF AKTIENGESELLSCHAFT (DE) 2001-04-12 WO disclosed
EP-1011678-A1 NICOTINE ANTAGONISTS FOR NICOTINE-RESPONSIVE NEUROPSYCHIATRIC DISORDERS UNIVERSITY OF SOUTH FLORIDA (US) 2000-06-28 EP disclosed
WO-2000035280-A1 EXO-R-MECAMYLAMINE FORMULATION AND USE IN TREATMENT UNIVERSITY OF SOUTH FLORIDA (US) 2000-06-22 WO disclosed
WO-2000035279-A1 EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT UNIVERSITY OF SOUTH FLORIDA (US) 2000-06-22 WO disclosed
WO-2000026194-A1 NOVEL 1-ARYL-4-THIOURACILS BASF AKTIENGESELLSCHAFT (DE) 2000-05-11 WO disclosed
US-6034079-A ADMINISTERING MECANYLAMINE AND NEUROLEPTIC AGENT UNIVERSITY OF SOUTH FLORIDA (US) 2000-03-07 US disclosed
WO-1999007378-A1 NICOTINE ANTAGONISTS FOR NICOTINE-RESPONSIVE NEUROPSYCHIATRIC DISORDERS THE UNIVERSITY OF SOUTH FLORIDA A Corporation of the State of Florida (US) 1999-02-18 WO disclosed
WO-1999007356-A1 NICOTINE ANTAGONISTS FOR NEUROPSYCHIATRIC DISORDERS UNIVERSITY OF SOUTH FLORIDA RESEARCH FOUNDATION, INC. (US) 1999-02-18 WO disclosed